Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

FINFAT multicenter trial results reported at IDF 97

July 23, 1997

Recombinant infertility drug launched in Canada

July 23, 1997

Economics of diabetes discussed at IDF 97

July 22, 1997

Hyperglycemia increases the risk of cardiovascular disease: epidemiological evidence

July 22, 1997

D1/D2 combination therapy results reported at the 16th IDF congress

July 22, 1997

RPR seeks approval for Menorest in Japan

July 22, 1997

U.S. patent allowance for Cypress Bioscience's IPM product

July 22, 1997

Steroids from Jenapharm for contraception/HRT

July 22, 1997

New treatment in development for Pompe's disease

July 21, 1997

Once-daily atorvastatin vs. pravastatin for hypercholesterolemia

July 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...